Effect of aspirin use on thiazolidinediones and cardiovascular events.
Konstantinopoulos
Panagiotis A
PA
Karamouzis
Michalis V
MV
Papavassiliou
Athanasios G
AG
D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077205:Pioglitazone; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors; D045162:Thiazolidinediones; D001241:Aspirin; D000077205:Pioglitazone